Equities

Hikma Pharmaceuticals PLC

HIK:LSE

Hikma Pharmaceuticals PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,540.00
  • Today's Change-12.00 / -0.77%
  • Shares traded1.15m
  • 1 Year change-32.87%
  • Beta1.1634
Data delayed at least 20 minutes, as of Feb 06 2026 14:55 GMT.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue3,1562,8752,517
OPERATING EXPENSES
Cost of revenue total1,7081,4681,252
Selling, general and admin. expenses, total568544509
Depreciation/amortization928892
Unusual expense(income)20260200
Other operating expenses, total184.0011
Total operating expense2,5472,5132,208
Operating income609362309
Other, net(84)(14)(11)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes455281233
Provision for income taxes938942
Net income after taxes362192191
Minority interest(3)(2)(3)
Net income before extra. Items359190188
Total extraordinary items------
Net income359190188
Inc.avail. to common excl. extra. Items359190188
Inc.avail. to common incl. extra. Items359190188
EPS RECONCILIATION
Basic/primary weighted average shares221221224
Basic/primary eps excl. extra items1.620.860.84
Basic/primary eps incl. extra items1.620.860.84
Dilution adjustment------
Diluted weighted average shares223222225
Diluted eps excl. extra items1.610.850.84
Diluted eps incl. extra items1.610.850.84
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.770.730.56
Gross dividend - common stock177159124
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental757359
SUPPLEMENTAL INCOME
Depreciation, supplemental979590
Total special items20260200
NORMALISED INCOME
Normalized income before taxes475541433
Effect of special items on income taxes(45)(42)(69)
Income tax excluding impact of special items4847(27)
Normalized income after tax427494460
Normalized income avail. to common424492457
Basic normalized EPS1.922.232.04
Diluted normalized EPS1.902.212.03
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.